Ubs Group Ag Imago Bio Sciences, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$15.03 - $35.96 $2.78 Million - $6.65 Million	185,064 Added 12495.88%	186,545 $6.71 Million
Q3 2022 Nov 10, 2022	BUY	$14.15 - $19.5 $20,956 - $28,879	1,481 New	1,481 $22,000
Q2 2022 Aug 10, 2022	SELL	$11.81 - $20.92 $15,211 - $26,944	-1,288 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $55,678 - $82,025	-3,281 Reduced 71.81%	1,288 $25,000
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $59,040 - $108,071	3,640 Added 391.82%	4,569 $108,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $14,864 - $26,792	929 New	929 $19,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.